Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Massachusetts General Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Dana-Farber Cancer Institute
Brigham and Women's Hospital
AstraZeneca
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00095836
First received: November 9, 2004
Last updated: March 3, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Publications: